Suppr超能文献

骨诱导蛋白递送的基本原理。

A rationale for delivery of osteoinductive proteins.

作者信息

Brekke J H

机构信息

THM Biomedical, Inc., Waterfront Plaza-Suite #608, 325 Lake Ave. South, Duluth, Minnesota 55802.

出版信息

Tissue Eng. 1996 Summer;2(2):97-114. doi: 10.1089/ten.1996.2.97.

Abstract

Highly pure, recombinant human osteoinductive proteins make it possible to consider programmable osteoneogenesis. Until recently, it was believed that a bioresorbable excipient or physiologic solution would suffice to transport osteoinductive agents from source to wound. After considering surgical requirements, particular bone wound circumstances, scarcity of collateral circulation, phenotype plasticity of mesenchymal progenitor cells, and the morphogens' pleiotrophic effects, it becomes clear that the issue of controlled, programmable osteoneogenesis is a more complicated proposition than can be addressed solely by application of osteoinductive protein. The essential characteristics of a manufactured bone graft substitute (BGS) device are dictated by demands placed on such a device by the surgeons who will employ them and the cells that will occupy them. This review outlines a design process for BGS devices that (1) begins by surveying BGS requirements gathered from the literature from 1991 to 1995, (2) briefly reviews recent in vitro studies of rhBMP-2 and OP- 1, (3) describes commonly encountered circumstances of recipient wound beds, (4) describes behaviors of mesenchymal cells involved in connective tissue repair and regeneration, and (5) concludes with a rationale for design of an osteoinductive bone graft substitute. Emerging from this process is a composite device consisting of a bioresorbable structural polymer, a filamentous velour of hyaluronan (HY), and an osteoinductive protein. The structural polymer, D,D-L,L-polylactic acid, fabricated in the architecture of cancellous bone, is capable of maintaining its structural and architectural properties after being thoroughly saturated with water. Within its interstices is located a filamentous velour of hyaluronan which, when fully hydrated, becomes a viscoelastic gel. It is anticipated that the osteoinductive protein will either be carried on the dried hyaluronic acid velour or in solution via the viscoelastic HY gel.

摘要

高纯度的重组人骨诱导蛋白使可程控性骨生成成为可能。直到最近,人们还认为生物可吸收赋形剂或生理溶液足以将骨诱导剂从来源处运输至伤口。在考虑了手术要求、特定骨伤口情况、侧支循环的缺乏、间充质祖细胞的表型可塑性以及形态发生素的多效性作用之后,很明显,可控的、可程控性骨生成问题比单纯应用骨诱导蛋白所能解决的问题更为复杂。人造骨移植替代物(BGS)装置的基本特性取决于使用它们的外科医生以及将占据这些装置的细胞对该装置的要求。本综述概述了BGS装置的设计过程,该过程:(1)首先调查1991年至1995年文献中收集的BGS要求;(2)简要回顾最近对重组人骨形态发生蛋白-2(rhBMP-2)和骨形成蛋白-1(OP-1)的体外研究;(3)描述受体伤口床常见的情况;(4)描述参与结缔组织修复和再生的间充质细胞的行为;(5)最后给出设计骨诱导性骨移植替代物的基本原理。从这个过程中产生的是一种复合装置,它由生物可吸收结构聚合物、透明质酸丝状绒布(HY)和骨诱导蛋白组成。结构聚合物D,D-L,L-聚乳酸,按照松质骨的结构制造,在完全被水饱和后仍能保持其结构和形态特性。在其空隙中放置着透明质酸丝状绒布,当完全水合时,它会变成粘弹性凝胶。预计骨诱导蛋白将通过干燥的透明质酸绒布携带,或者通过粘弹性HY凝胶以溶液形式携带。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验